✦ LIBER ✦

A phase II study of neoadjuvant docetaxel plus doxorubicin (KBCS-01) in stage II, III breast cancer

✍ Scribed by Sehwan Han; Sung Bae Kim; Sung S. Kang; Woo C. Noh; Nam S. Paik; Eil S. Chang; Jae-Ryong Kim; Sook-Hyun Lim; Hee-Suk Park

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Neoadjuvant Chemothera

✍ Bhuvaneswari Ramaswamy; Steven P Povoski; Chris Rhoades; Joan Allen; Marsha Haug 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 227 KB

A randomized phase-III trial of docetaxe

✍ Keun Seok Lee; Jungsil Ro; Byung-Ho Nam; Eun Sook Lee; Youngmee Kwon; Hye Soo Kw 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 285 KB

Phase II study of doxorubicin plus ifosf

✍ Michael J. Millward; Adrian L. Harris; Brian M. J. Cantwell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 1 views

Phase 2 study of neoadjuvant treatment w

✍ A. J. Montero; C. M. Diaz-Montero; Y. E. Deutsch; J. Hurley; L. G. Koniaris; T. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 398 KB

A phase-III trial of doxorubicin and doc

✍ Philippe A. Cassier; Sylvie Chabaud; Véronique Trillet-Lenoir; Pierre-Yves Peaud 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 233 KB

A phase II study of weekly docetaxel in

✍ Hugo E. R. Ford; Yoon-Sim Yap; David W. Miles; Andreas Makris; Marcia Hall; Liz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB